Ross Muken
Stock Analyst at Evercore ISI Group
(2.82)
# 1,924
Out of 5,044 analysts
47
Total ratings
61.54%
Success rate
4.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Outperform | $190 → $200 | $187.93 | +6.42% | 9 | Oct 3, 2025 | |
| HSIC Henry Schein | Maintains: In-Line | $78 → $70 | $63.21 | +10.74% | 10 | Aug 6, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $170 → $240 | $177.73 | +35.04% | 9 | Jul 25, 2025 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $145.85 | -10.87% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $47.95 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $162.79 | -58.84% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $97.80 | +155.62% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $557.63 | -60.55% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $13.41 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Oct 3, 2025
Maintains: Outperform
Price Target: $190 → $200
Current: $187.93
Upside: +6.42%
Henry Schein
Aug 6, 2025
Maintains: In-Line
Price Target: $78 → $70
Current: $63.21
Upside: +10.74%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $170 → $240
Current: $177.73
Upside: +35.04%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $145.85
Upside: -10.87%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $47.95
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $162.79
Upside: -58.84%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $97.80
Upside: +155.62%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $557.63
Upside: -60.55%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $13.41
Upside: -